Avadel Pharmaceuticals Plc
(NASDAQ: AVDL)
|
8:00 PM UTC, 10/21/25 | |||
---|---|---|---|---|
Last: $17.87 | Change: +2.07 | %Change: +13.10% | Volume: 6,776,789 |
Open: | $ 15.80 | Volume: | 6,776,789 | |
---|---|---|---|---|
High: | $ 18.41 | Yield(%) | 0.00 | |
Low: | $ 15.63 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 1.48B | |
EPS ($) | -0.03 | Shares Out: | 97.10M |
% Price Change (last 4 weeks): | 14.62 |
---|---|
% Price Change (last 13 weeks): | 59.13 |
% Price Change (last 26 weeks): | 116.08 |
% Price Change (last 52 weeks): | 30.63 |
% Price Change (year to date): | 70.03 |
Quick Ratio (x): | n/a |
---|---|
Current Ratio (x): | n/a |
LT Debt/Equity (%): | n/a |
Total Debt/Equity (%): | n/a |
|
|
50-day Moving Average: | $14.99 |
---|---|
200-day Moving Average: | $10.46 |
Avg. Daily Vol. (last 50 days): | 1,450,983 |
Avg. Daily Vol. (last 200 days): | 1,377,791 |
52-wk high: | $16.66 |
52-wk low: | $6.38 |
Bid: | $18.00 |
Ask: | $18.13 |
Avadel Pharmaceuticals Plc
Ten Earlsfort Terrace Dublin 2 D02 T380 Phone: +353 1 901 5201 Fax: n/a http://www.avadel.com |
Net Operating Cash Flow (n/a ): | n/a |
---|---|
Net Operating Margin (%): | n/a |
Pretax Profit Margin (%): | n/a |
Return on Equity (%): | n/a |
---|---|
Return on Assets (%): | n/a |
Return on Invested Capital (%): | n/a |
Sales/turnover (n/a ): | n/a |
---|---|
Deprec. & Amoritiz (n/a ): | n/a |
Operating Income (n/a ): | n/a |
EPS - Excl. Extraordinary Items: | n/a |